The Role of Tau Protein in Diseases
Open Access
- 9 April 2018
- journal article
- Published by Heighten Science Publications Corporation in Annals of Advances in Chemistry
- Vol. 2 (1), 001-016
- https://doi.org/10.29328/journal.aac.1001010
Abstract
Amyloid-β peptide (Aβ) and tau protein deposits in the human brain are the pathological hallmarks of Alzheimer’s disease (AD).Keywords
This publication has 91 references indexed in Scilit:
- Effect of TTP488 in patients with mild to moderate Alzheimer’s diseaseBMC Neurology, 2014
- Intranasal Insulin as a Treatment for Alzheimer’s Disease: A Review of Basic Research and Clinical EvidenceCNS Drugs, 2013
- Relationship between central and peripheral fatty acids in humansLipids in Health and Disease, 2013
- The Many Faces of TauNeuron, 2011
- Epidemiology of Alzheimer diseaseNature Reviews Neurology, 2011
- Amyloid-β/Fyn–Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's DiseaseJournal of Neuroscience, 2011
- Free radical damage to cerebral cortex in Alzheimer's disease, microvascular brain injury, and smokingAnnals of Neurology, 2009
- Effects of 5‐HT6 receptor antagonism and cholinesterase inhibition in models of cognitive impairment in the ratBritish Journal of Pharmacology, 2008
- The amino terminus of tau inhibits kinesin‐dependent axonal transport: Implications for filament toxicityJournal of Neuroscience Research, 2008
- Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and preventionJournal of Cellular and Molecular Medicine, 2008